Clinical TrialsSearch results
Number of results: 261
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma(JCOG0110, GCSSG-SPNX)
- T2, T3, and T4 carcinoma in the proximal third of the stomach
- Japan Clinical Oncology Group(JCOG)
- 2005-06-07
Other
- Docetaxel(D) versus docetaxel plus gemcitabine(DG) for second-line treatment of non-small cell lung cancer (NSCLC) : Results of a JCOG randomized trial (JCOG0104)
- Non-small cell Lung Cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-07-22
Other
- A randomized controlled trial to evaluate the efficacy of intra-pericardial instillation of a sclerosing agent after pericardial drainage in patients with malignant pericardial effusion associated with lung cancer (JCOG9811).
- Malignant pericardial effusion
- Japan Clinical Oncology Group(JCOG)
- 2005-07-28
Other
- A phase I/II study of transjugular-transhepatic peritoneo-venous shunting for malignant ascites (JIVROSG-0201)
- Cancer-related refractory ascites
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-05
Other
- A phase II study of percutaneous trans-esophageal gastric tubing for malignant gastrointestinal obstruction (JIVROSG-0205)
- Malignant gastrointestinal obstruction
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-06
Other
- A phase III study of covered versus bare metallic stents for the treatment of malignant bile duct obstruction (JIVROSG-0207)
- Malignant common bile duct obstruction
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-06
Other
- Phase I/II study of hepatic arterial infusion chemotherapy of gemcitabine for unresectable cholangiocarcinoma (JIVROSG-0301)
- Unresectable cholangiocarcinoma
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-07
Other
- Phase III Randomized Adjuvant Study of Chemotherapy in Node Positive Breast Cancer Patients -AC(Anthracycline-Cyclophosphamide) 4 cycles followed by Taxane 4 cycles (AC-Tac) versus Taxane 8 cycles and Paclitaxel versus Docetaxel-
- node positive breast cancer
- N-SAS BC 02 executive committee
- 2005-08-12
Other
- Phase III Randomized Adjuvant Study of Exemestane Versus Anastrozole Versus Tamoxifen in Hormone-Responsive Postmenopausal Breast Cancer Patients
- hormone-responsive postmenopausal primary breast cancer
- N-SAS BC 04 executive committee
- 2005-08-12
Other
- Evaluation of feasibility and accuracy of diagnosis using sentinel node biopsy in early gastric cancer(JCOG0302, GCSSG-SNB)
- gastric neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2005-08-15